PRESS RELEASE published on 02/20/2025 at 18:30, 1 year 1 month ago Inside Information / Operations of the issuer (acquisitions, sales...) Theraclion secures financing of €6 million through a convertible bond loan with firm commitments from historical shareholders, Furui and Unigestion. CEO Martin Deterre highlights strategic priorities for revenue growth and FDA approval Financing Strategic Priorities FDA Approval Theraclion Convertible Bond Loan
PRESS RELEASE published on 02/20/2025 at 18:30, 1 year 1 month ago Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...) Theraclion sécurise un financement de 6 millions d'euros auprès de ses actionnaires historiques grâce à un emprunt obligataire convertible. Objectif : poursuite R&D et développement commercial Actionnaires Financement Emprunt Theraclion Obligataire Convertible
BRIEF published on 02/07/2025 at 18:35, 1 year 2 months ago Publication des comptes ajustés de Theraclion pour le premier semestre 2024 Trésorerie Theraclion Comptes Ajustés Ultrasons Focalisés Marche Des Varices
BRIEF published on 02/07/2025 at 18:35, 1 year 2 months ago Publication of Theraclion's adjusted accounts for the first half of 2024 Treasury Theraclion Adjusted Accounts Focused Ultrasound Varicose Veins Walk
PRESS RELEASE published on 02/07/2025 at 18:30, 1 year 2 months ago Informations privilégiées / Communiqué sur comptes, résultats Publication des comptes ajustés du premier semestre 2024 de Theraclion, société innovante en thérapie ultrasonique pour varices. Focus sur recentrage stratégique et résultats financiers Stratégie Résultats Financiers Theraclion Varices Comptes Ajustés
BRIEF published on 01/06/2025 at 19:06, 1 year 3 months ago Theraclion 2024 Review: Progress and Challenges Turnover Theraclion SONOVEIN® FDA Clinical Trial Product Maturity
BRIEF published on 01/06/2025 at 19:06, 1 year 3 months ago Bilan 2024 de Theraclion : avancées et défis Chiffre D'affaires Theraclion SONOVEIN® Essai Clinique FDA Maturité Produit
PRESS RELEASE published on 01/06/2025 at 19:01, 1 year 3 months ago Informations privilégiées / Communiqué sur comptes, résultats THERACLION fait le bilan de ses réalisations en 2024, mettant en avant les avancées de son essai clinique pivot FDA et la maturité de son produit SONOVEIN® pour traitement des varices 2024 Essai Clinique Theraclion SONOVEIN® Varices
BRIEF published on 10/30/2024 at 19:05, 1 year 5 months ago Theraclion: Results for the First Half of 2024 and Strategic Outlook Financial Results Theraclion SONOVEIN FDA America Marketing 2025
BRIEF published on 10/30/2024 at 19:05, 1 year 5 months ago Theraclion : Résultats du Premier Semestre 2024 et Perspectives Stratégiques Résultats Financiers Theraclion SONOVEIN FDA Amérique Commercialisation 2025
Published on 04/14/2026 at 17:00, 31 minutes ago Intention to List on the Namibia Securities Exchange
Published on 04/14/2026 at 15:05, 2 hours 26 minutes ago Karbon-X Expands Canadian Compliance Offering as Regulatory Deadlines Approach Across Federal and Provincial Carbon Markets
Published on 04/14/2026 at 15:00, 2 hours 31 minutes ago Datavault AI and AgSensor Solutions Announce Consulting Partnership to Tokenize High-Value Agricultural Data Assets
Published on 04/14/2026 at 14:55, 2 hours 36 minutes ago BEACN Introduces Voice-First Headset as It Expands Its Creator Audio Platform
Published on 04/14/2026 at 14:30, 3 hours 1 minute ago Goldcliff Extends Kettle Valley Drill Permit to 2028 and Completes Trench Program Advancing North Cliff Zone Targets
Published on 04/14/2026 at 17:24, 6 minutes ago EQS-Adhoc: tick Trading Software AG raises forecast for the current business year 2025/2026
Published on 04/14/2026 at 17:09, 21 minutes ago Annual General Meeting V-ZUG: Shareholders approve all proposals
Published on 04/14/2026 at 17:03, 28 minutes ago Kickoff for automated drone defense from Brandenburg: Joint venture ONBERG begins operations
Published on 04/14/2026 at 17:00, 30 minutes ago Vesper Next Generation Infrastructure Fund I, and co-investment initiatives, reach final close surpassing in aggregate EUR 1bn of total AuM, the most successful debut mid-market infrastructure funds since 2023
Published on 04/14/2026 at 16:00, 1 hour 31 minutes ago Open-air driving pleasure in the new Porsche 911 GT3 S/C
Published on 04/14/2026 at 17:00, 31 minutes ago FinanceWire Introduces Certidox to Enable Verifiable Press Releases as Fake Content Becomes Indistinguishable from Reality
Published on 04/14/2026 at 17:00, 31 minutes ago FinanceWire intègre Certidox pour permettre la vérification des communiqués de presse, alors que les contenus falsifiés deviennent impossibles à distinguer de la réalité
Published on 04/14/2026 at 08:30, 9 hours 1 minute ago ALPOU - Groupe POULAILLON - Projet offre publique d'achat obligatoire
Published on 04/13/2026 at 19:14, 22 hours 16 minutes ago ALTAREA - Déclaration d’opérations sur actions propres
Published on 04/13/2026 at 18:15, 23 hours 16 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/03/2026
